Cambridge Investment Research Advisors’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $8.06M | Buy |
|
|||||
|
2025
Q2 | $3.8M | Buy |
|
|||||
|
2025
Q1 | $3.1M | Buy |
|
|||||
|
2024
Q4 | $2.29M | Sell |
|
|||||
|
2024
Q3 | $3.9M | Sell |
|
|||||
|
2024
Q2 | $3.55M | Buy |
|
|||||
|
2024
Q1 | $3.68M | Sell |
|
|||||
|
2023
Q4 | $3.98M | Buy |
|
|||||
|
2023
Q3 | $296K | Sell |
|
|||||
|
2023
Q2 | $267K | Sell |
|
|||||
|
2023
Q1 | $788K | Buy |
|
|||||
|
2022
Q4 | $262K | Sell |
|
|||||
|
2022
Q3 | $1.66M | Buy |
|
|||||
|
2022
Q2 | $402K | Sell |
|
|||||
|
2022
Q1 | $606K | Sell |
|
|||||
|
2021
Q4 | $517K | Buy |
|
|||||
|
2021
Q3 | $597K | Sell |
|
|||||
|
2021
Q2 | $640K | Sell |
|
|||||
|
2021
Q1 | $2.55M | Buy |
|
|||||
|
2020
Q4 | $1.71M | Buy |
|
|||||
|
2020
Q3 | $1.71M | Buy |
|
|||||
|
2020
Q2 | $1.52M | Sell |
|
|||||
|
2020
Q1 | $1.11M | Buy |
|
|||||
|
2019
Q4 | $983K | Buy |
|
|||||
|
2019
Q3 | $871K | Buy |
|
|||||
|
2019
Q2 | $978K | Buy |
|
|||||
|
2019
Q1 | $560K | Buy |
|
|||||
|
2018
Q4 | $396K | Sell |
|
|||||
|
2018
Q3 | $416K | Buy |
|
|||||
|
2018
Q2 | $432K | Buy |
|
|||||
|
2018
Q1 | $402K | Buy |
|
|||||
|
2017
Q4 | $446K | Sell |
|
|||||
|
2017
Q3 | $414K | Buy |
|
|||||
|
2017
Q2 | $334K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $168K | Sell |
|
|||||
|
2016
Q3 | $212K | Buy |
|